Investment portfolio (31/12/2025).
We provide smart capital for Belgian innovation and driving socio-economic growth.
Our role is to create
sustainable long-term value.
all our investments are driven by our values.
IN2ACTION CAPITAL CV
Détention du capital13.19 %
The founders of the Down2Earth Capital fund, which was set up in 2013 as a fund specialising in buyouts and the provision of growth capital to Belgian SMEs, have set up a new private equity fund: In2Action Capital. It will focus mainly on companies in financial difficulty or in need of strategic reorientation, operating entities that no longer form a core business of a large group and family businesses facing succession issues.
IN2ACTION CAPITAL OVERFLOW VC
Détention du capital13.19 %
The founders of the Down2Earth Capital fund, which was set up in 2013 as a fund specialising in buyouts and the provision of growth capital to Belgian SMEs, have set up a new private equity fund: In2Action Capital. It will focus mainly on companies in financial difficulty or in need of strategic reorientation, operating entities that no longer form a core business of a large group and family businesses facing succession issues
INBIOSE
Détention du capital37 %
Inbiose is an industrial biotechnology company that was incorporated as a spin-off from Ghent University in 2013. It produces complex sugars by means of fermentation deploying specific micro-organisms by means of a unique (and patented) technology platform, GlycoActives.
INDUSTRYA FUND
Détention du capital11.90 %
The Industrya fund is dedicated to researching, identifying, supporting, hosting and investing in industrial start-ups and scale-ups. The fund is mainly active in the industrial sectors of energy transition, industry 4.0 and materials and will support start-ups and scale-ups deemed strategic for the development of Belgian and European industry.
INNOVATION FUND
Détention du capital13.80 %
Innovation Fund is a limited company whose area of activity is to act as investment fund focussed on innovative ‘early stage’ and ‘venture’ companies in the field of the chemical industry through financing, consulting and assistance in policy and management.
INVENTURES II
Détention du capital15.3 %
Inventures II is a “Venture Capital Fund” with Belgian impact, managed by Inventures Investment Partners NV. This fund invests in start-ups and scale-ups in Belgium (and neighboring countries) that fulfill at least 17 sustainable Development goals as mentioned by the United Nations. The fund focuses mainly on education, health, “smart cities”, renewable energy and sustainable food production.
ION BEAM APPLICATIONS (IBA)
Détention du capital0.19 %
A world leader in diagnosis of cancer cases (dosimetry) as well as the development of innovative tools to treat them via proton therapy.
IP4SI Investment platform for sustainable infrastructure
Détention du capital20 %
ISTAR MEDICAL
Détention du capital9.53 %
Company that develops eye implants, which is the result from the exploitation of the STAR biomaterial, developed by the University of Washington in Seattle, USA.
ITEOS THERAPEUTICS
Détention du capital0.12 %
iTeos Therapeutics is a common spin-off of het Ludwig Institute for Cancer Research (L.I.C.R.) and the Duve Institute of the Université Catholique de Louvain (U.C.L.). The goal is to combine their expertise in immunotherapy and tumor immunology for the development of innovative anti-cancer treatments.
ITINERIS
Détention du capital3.8 %
Itineris' UMAX software enables utilities (e.g. water and electricity) to manage their interactions with customers. The most important module is the billing system, but the possibilities of the software are much broader.
John cockerill hydrogene
Détention du capital4.86 %
Junction Growth Fund
Détention du capital8.71 %